Related Experiment Video

Updated: Jul 4, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

The tumour suppressor RASSF1A is a novel substrate of PKC

Sunil K Verma1, Trivadi S Ganesan, Peter J Parker

  • 1Department of Medical Oncology, Medical Sciences Division, The University of Oxford, Oxford, UK.

FEBS Letters
|June 3, 2008
PubMed

Insights

Protein kinase C (PKC) phosphorylates the tumor suppressor RASSF1A at specific sites. This phosphorylation is crucial for RASSF1A

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Ras association domain family 1A (RASSF1A) is a tumor suppressor protein.
  • RASSF1A possesses a C1 domain similar to protein kinase C (PKC) and an RA domain.
  • The role of RASSF1A in cellular processes and its regulation by kinases are not fully understood.

Purpose of the Study:

  • To investigate whether RASSF1A is a substrate for PKC.
  • To identify the specific sites of RASSF1A phosphorylation by PKC.
  • To determine the functional consequences of RASSF1A phosphorylation on microtubule organization.

Main Methods:

  • Biochemical assays were employed to study RASSF1A-PKC interactions.
  • In vitro and in vivo phosphorylation of RASSF1A by PKC was assessed.
  • Site-directed mutagenesis (S197, 203D and AA mutants) was used to analyze phosphorylation effects.

Main Results:

  • RASSF1A was identified as a direct substrate of PKC.
  • Serine residues S197 and S203 within the RASSF1A RA domain are phosphorylated by PKC.
  • Phosphorylation-deficient mutants (S197, 203D) lost the ability to modulate microtubule organization and vimentin collapse, unlike WT and phosphomimetic AA mutants.

Conclusions:

  • PKC-mediated phosphorylation of RASSF1A at S197 and S203 is a key regulatory mechanism.
  • This phosphorylation event is essential for RASSF1A's function in reorganizing the microtubule network.
  • Findings highlight a novel regulatory pathway involving PKC and RASSF1A in cellular structure maintenance.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...